tazobactam has been researched along with fosfomycin in 7 studies
| Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (fosfomycin) | Trials (fosfomycin) | Recent Studies (post-2010) (fosfomycin) |
|---|---|---|---|---|---|
| 1,327 | 153 | 694 | 2,335 | 181 | 1,022 |
| Protein | Taxonomy | tazobactam (IC50) | fosfomycin (IC50) |
|---|---|---|---|
| UDP-N-acetylglucosamine 1-carboxyvinyltransferase | Escherichia coli K-12 | 3.5795 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, PNA | 1 |
| Avery, LM; Nicolau, DP; Sutherland, CA | 1 |
| Cayô, R; Cuba, GT; Gales, AC; Kiffer, CRV; Nicolau, DP; Nodari, CS; Pignatari, ACC; Rocha-Santos, G; Streling, AP | 1 |
| Abou Chakra, M; Dellis, A; Moussa, M; Moussa, Y; Papatsoris, A | 1 |
| Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E | 1 |
| Guery, B; Jacot, D; Papadimitriou-Olivgeris, M | 1 |
| Albur, M; Attwood, M; Griffin, P; Macgowan, AP; Noel, AR | 1 |
2 review(s) available for tazobactam and fosfomycin
| Article | Year |
|---|---|
Pharmacotherapeutic advances for recurrent urinary tract infections in women.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Beverages; Ceftazidime; Cephalosporins; Drug Combinations; Female; Fosfomycin; Humans; Recurrence; Secondary Prevention; Tazobactam; Urinary Tract Infections; Vaccinium macrocarpon | 2020 |
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin | 2021 |
5 other study(ies) available for tazobactam and fosfomycin
| Article | Year |
|---|---|
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?
Topics: Fosfomycin; Humans; Piperacillin; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2019 |
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States | 2019 |
In vitro synergy of ceftolozane/tazobactam in combination with fosfomycin or aztreonam against MDR Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
How to Manage Pseudomonas aeruginosa Infections.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2022 |
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
Topics: Anti-Bacterial Agents; Cephalosporins; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin | 2023 |